John F. Kennedy Jr. Forum, Harvard Kennedy School, 79 JFK Street, Cambridge, MA
Iris Bohnet, Professor of Public Policy, Director, Women and Public Policy Program, Co-Chair, Behavioral Insights Group, Harvard Kennedy School; moderated by Meghna Chakrabarti, Host of Radio Boston, WBUR
Diversity is a moral and a business imperative. But unconscious bias holds us back, and debiasing people’s minds has proven to be difficult and expensive. Behavioral design offers a new solution. Professor Iris Bohnet will discuss what organizations can do to create more inclusive environments, level the playing field, and help diverse teams succeed. There is so...
Join Professor Michael Luca for an interactive discussion about his research identifying discrimination on Airbnb, as well as the market design choices that online platforms such as Airbnb might make to foster a more inclusive marketplace. Lunch will be served.
Please join former CPL Hauser Leader-in-Residence and former African Development Bank President Donald Kaberuka for a conversation about the African Union Peace Fund. Direct from the UN General Assembly, Dr. Kaberuka will share his reflections as High Representative of the AU Peace Fund.
Join us for a conversation with Juliette Kayyem, Belfer Lecturer in International Security on September 23, 2016 from 9:00-10:00 a.m. Kayyem is known for her work on homeland security efforts and has served as a member of the National Commission on Terrorism as well as President Obama’s Assistant Secretary for Intergovernmental Affairs at the Department...
Join the Behavioral Insights Student Group and the Experimental Pitch Innovation Competition for a discussion with Francesca Gino of Harvard Business School. Francesca will discuss the latest research in behavioral science, and her own work with organizations.
Rand Wentworth, president emeritus of the Land Trust Alliance and CPL Louis Bacon Senior Fellow in Environmental Leadership, will speak at CPL on September 20, 2016 from 12:00-1:00 p.m. Wentworth will discuss his tenure as president of the Land Trust Alliance, during which the organization lobbied Congress to dramatically expand the funding and tax incentives for conservation, doubling the pace of conservation in the U.S. He will also discuss his personal leadership trajectory and his new role as a resource for HKS students and the greater...
Join BIG for the introduction to our Experimental Pitch Innovation Competition (EPIC), an opportunity for students from any school to learn about the nitty-gritty of running experiments and applying behavioral science to their own work. This session will introduce the program, overview the workshop and pitch competition, and discuss the "behavioral economics revolution" in government and business.
Join the Behavioral Insights Student Group for a discussion with Erez Yoeli from the Harvard University Program on Evolutionary Dynamics, on "Strategies for Engaging People's Desire to Do Good." How can we get people to do more good? To contribute, volunteer, and conserve more, and to choose sustainable products? Erez will present a simple framework for understanding why people do good—but sometimes not enough of it. Then, he'll use these insights to provide guidelines for more effective engagement, illustrated with real-world behavioral interventions.
Join us for a conversation with Tommy Amaker, the Thomas G. Stemberg '71 Family Endowed Coach for Harvard Men's Basketball. Since taking over as head coach in 2007, Amaker has transformed the program into a powerhouse, with four NCAA tournament appearances and five Ivy League championships, as well as Harvard's first appearance in a major...
Waterhouse Room, Gordon Hall 106, Harvard Medical School, 25 Shattuck Street Boston, MA 02115
This event is organized by the Center for Bioethics at Harvard Medical School.
There is a growing push to incorporate patient voices more directly at the FDA in decision-making about investigational drugs, but what are the optimal parameters of patients' contributions?
How should individual patient voices be weighed against the accumulated data about a drug?
Can we better educate patients to equip them to engage in discussions about trial design, statistics, and evaluation?
How should we consider financial relationships between patient...